Xeris Biopharma Holdings Inc (XERS)
Operating Expenses
$74.42M
Quarterly · Period ending: · USD
XERS Operating Expenses
Latest reported$74.42Mperiod ending
Latest reported$74.42Mperiod ending
XERS Quarterly Operating Expenses ($5.00M → $74.42M)
Quarterly operating expenses
High-resolution chart · PNG
XERS operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 74,415,000 | |
| 61,927,000 | |
| 49,955,000 | |
| 56,653,000 | |
| 52,448,000 | |
| 54,481,000 | |
| 48,942,000 | |
| 53,568,000 | |
| 45,752,000 | |
| 48,912,000 | |
| 43,950,000 | |
| 45,032,000 | |
| 46,432,000 | |
| 41,154,000 | |
| 42,023,000 | |
| 43,245,000 | |
| 39,412,000 | |
| 44,874,000 | |
| 65,051,000 | |
| 32,173,000 | |
| 31,310,000 | |
| 23,109,000 | |
| 23,108,000 | |
| 20,360,000 | |
| 22,933,000 | |
| 28,252,000 | |
| 33,062,000 | |
| 30,395,000 | |
| 34,357,000 | |
| 25,685,000 | |
| 21,115,000 | |
| 15,525,000 | |
| 13,176,000 | |
| 11,951,000 | |
| 9,676,000 | |
| 7,742,000 | |
| 5,760,000 | |
| 5,003,000 |